RASopathies: From Germline Mutations to Somatic and Multigenic Diseases

Overview

Journal Biomed J

Publisher Elsevier

Specialty General Medicine

Date 2021 Jun 27

PMID 34175492

Citations 30

Authors

Quentin Riller

Frederic Rieux-Laucat

Affiliations

Soon will be listed here.

Abstract

The RAS-RAF-MEK-ERK signaling pathway is vital for different cellular mechanisms including cell proliferation, differentiation and apoptosis. This importance is highlighted by the high prevalence of mutations in RAS or related proteins of the pathway in cancers. More recently, development abnormalities have been linked to various germline mutations in this pathway and called RASopathies. Interestingly, rare disorders such as RAS-associated leukoproliferative diseases and histiocytosis have also been recently linked to multiple mutations in the same pathway, sometimes with the same mutation. This review will focus on germline RASopathies and rare somatic RASopathies and focus on how gain-of-function mutations in the same pathway can lead to various diseases.

Citing Articles

Trametinib as a targeted treatment in cardiac and lymphatic presentations of Noonan syndrome.

De Brouchoven I, Lorand J, Bofferding L, Sorlin A, Van Damme A, Danhaive O Front Pediatr. 2025; 13:1475143.

PMID: 40041314 PMC: 11876372. DOI: 10.3389/fped.2025.1475143.

Noonan Syndrome: Relation of Genotype to Cardiovascular Phenotype-A Multi-Center Retrospective Study.

Ilic N, Krasic S, Maric N, Gasic V, Krstic J, Cvetkovic D Genes (Basel). 2024; 15(11).

PMID: 39596663 PMC: 11594011. DOI: 10.3390/genes15111463.

Somatic mutations in autoinflammatory and autoimmune disease.

Torreggiani S, Castellan F, Aksentijevich I, Beck D Nat Rev Rheumatol. 2024; 20(11):683-698.

PMID: 39394526 DOI: 10.1038/s41584-024-01168-8.

Whole-exome sequencing reveals the genetic causes and modifiers of moyamoya syndrome.

Nakamura A, Nomura S, Hara S, Thamamongood T, Maehara T, Nariai T Sci Rep. 2024; 14(1):22720.

PMID: 39367156 PMC: 11452616. DOI: 10.1038/s41598-024-72043-5.

Germline mutations in a G protein identify signaling cross-talk in T cells.

Ham H, Jing H, Lamborn I, Kober M, Koval A, Berchiche Y Science. 2024; 385(6715):eadd8947.

PMID: 39298586 PMC: 11811912. DOI: 10.1126/science.add8947.

References

Cirstea I, Kutsche K, Dvorsky R, Gremer L, Carta C, Horn D . A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat Genet. 2009; 42(1):27-9. PMC: 3118669. DOI: 10.1038/ng.497. View

Nava C, Hanna N, Michot C, Pereira S, Pouvreau N, Niihori T . Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome. J Med Genet. 2007; 44(12):763-71. PMC: 2652823. DOI: 10.1136/jmg.2007.050450. View

Diamond E, Durham B, Haroche J, Yao Z, Ma J, Parikh S . Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer Discov. 2015; 6(2):154-65. PMC: 4744547. DOI: 10.1158/2159-8290.CD-15-0913. View

Gripp K, Morse L, Axelrad M, Chatfield K, Chidekel A, Dobyns W . Costello syndrome: Clinical phenotype, genotype, and management guidelines. Am J Med Genet A. 2019; 179(9):1725-1744. PMC: 8238015. DOI: 10.1002/ajmg.a.61270. View

Schubbert S, Zenker M, Rowe S, Boll S, Klein C, Bollag G . Germline KRAS mutations cause Noonan syndrome. Nat Genet. 2006; 38(3):331-6. DOI: 10.1038/ng1748. View

Cordeddu V, Di Schiavi E, Pennacchio L, Maayan A, Sarkozy A, Fodale V . Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet. 2009; 41(9):1022-6. PMC: 2765465. DOI: 10.1038/ng.425. View

Hervier B, Haroche J, Arnaud L, Charlotte F, Donadieu J, Neel A . Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. Blood. 2014; 124(7):1119-26. DOI: 10.1182/blood-2013-12-543793. View

Oliveira J, Bidere N, Niemela J, Zheng L, Sakai K, Nix C . NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci U S A. 2007; 104(21):8953-8. PMC: 1885609. DOI: 10.1073/pnas.0702975104. View

Niemeyer C . RAS diseases in children. Haematologica. 2014; 99(11):1653-62. PMC: 4222471. DOI: 10.3324/haematol.2014.114595. View

10.

Durham B, Roos-Weil D, Baillou C, Cohen-Aubart F, Yoshimi A, Miyara M . Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. Blood. 2017; 130(2):176-180. PMC: 5510787. DOI: 10.1182/blood-2016-12-757377. View

11.

Quilliam L, Rebhun J, Castro A . A growing family of guanine nucleotide exchange factors is responsible for activation of Ras-family GTPases. Prog Nucleic Acid Res Mol Biol. 2002; 71:391-444. DOI: 10.1016/s0079-6603(02)71047-7. View

12.

Stephens K, Weaver M, Leppig K, Maruyama K, Emanuel P, Le Beau M . Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies. Blood. 2006; 108(5):1684-9. PMC: 1895516. DOI: 10.1182/blood-2005-11-011486. View

13.

Pandit B, Sarkozy A, Pennacchio L, Carta C, Oishi K, Martinelli S . Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet. 2007; 39(8):1007-12. DOI: 10.1038/ng2073. View

14.

Tartaglia M, Pennacchio L, Zhao C, Yadav K, Fodale V, Sarkozy A . Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet. 2006; 39(1):75-9. DOI: 10.1038/ng1939. View

15.

Bader-Meunier B, Cave H, Jeremiah N, Magerus A, Lanzarotti N, Rieux-Laucat F . Are RASopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus? Case report and systematic review of the literature. Semin Arthritis Rheum. 2013; 43(2):217-9. DOI: 10.1016/j.semarthrit.2013.04.009. View

16.

Boon L, Mulliken J, Vikkula M . RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev. 2005; 15(3):265-9. DOI: 10.1016/j.gde.2005.03.004. View

17.

Calvo K, Price S, Braylan R, Oliveira J, Lenardo M, Fleisher T . JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities. Blood. 2015; 125(18):2753-8. PMC: 4424627. DOI: 10.1182/blood-2014-11-567917. View

18.

Gutmann D, Ferner R, Listernick R, Korf B, Wolters P, Johnson K . Neurofibromatosis type 1. Nat Rev Dis Primers. 2017; 3:17004. DOI: 10.1038/nrdp.2017.4. View

19.

Komatsuzaki S, Aoki Y, Niihori T, Okamoto N, Hennekam R, Hopman S . Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies. J Hum Genet. 2010; 55(12):801-9. DOI: 10.1038/jhg.2010.116. View

20.

Niemeyer C, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U . Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood. 1997; 89(10):3534-43. View